Absolute lymphocyte count is a prognostic marker in Covid-19: A retrospective cohort review
- PMID: 32779838
- PMCID: PMC7405282
- DOI: 10.1111/ijlh.13288
Absolute lymphocyte count is a prognostic marker in Covid-19: A retrospective cohort review
Abstract
Introduction: Prognostic factors are needed to aid clinicians in managing Covid-19, a respiratory illness. Lymphocytopenia has emerged as a simply obtained laboratory value that may correlate with prognosis.
Methods: In this article, we perform a retrospective cohort review study on patients admitted to one academic hospital for Covid-19 illness. We analyzed basic demographic, clinical, and laboratory data to understand the relationship between lymphocytopenia at the time of hospital admission and clinical outcomes.
Results: We discovered that lymphocyte count is lower (P = .01) and lymphocytopenia more frequent by an odds ratio of 3.40 (95% CI: 1.06-10.96; P = .04) in patients admitted to the Intensive Care Unit (ICU), a marker of disease severity, relative to those who were not. We additionally find that patients with lymphocytopenia were more likely to develop an acute kidney injury (AKI), a marker of organ failure, during admission by an odds ratio of 4.29 (95% CI: 1.35-13.57; P = .01).
Conclusion: This evidence supports the hypothesis that lymphocytopenia can be an early, useful, and easily obtained, prognostic factor in determining the clinical course and disease severity of a patient admitted to the hospital for Covid-19.
Keywords: SARS-CoV-2 infection; acute kidney injury; covid-19; lymphopenia; prognosis.
© 2020 John Wiley & Sons Ltd.
Conflict of interest statement
None declared for JW, AD, SL, AF, and BC.
Figures
References
-
- Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020. https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa272/ - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
